The following is shared from a January 18 memorandum from the CMS Directors, Quality, Safety & Oversight Group (QSOG) and Survey & Operations Group (SOG):
Memorandum Summary
- Donor Definition: CMS is clarifying the definition of “donor” in the Organ Procurement Organization (OPO) Conditions for Coverage (CfCs). This clarification addresses the use of the pancreata for islet cell research that are included in the definition (emphasis added).
- Data Verification: OPOs must maintain information on the disposition of pancreas organs and islet cells submitted for pancreatic islet cell research.